healthday1h
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...
Some people say they're 'allergic to their period.' Here's what to know about the autoimmune skin condition that causes it.
An allergist, dermatologist, and OB-GYN explain how progesterone dermatitis presents and which treatments can help you ease ...
Medpage Today on MSN2d
FDA Approves New IL-31 Drug for Eczema
A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...
Hosted on MSN2d
Hand, Foot and Mouth Disease: What It Is, Causes, Symptoms & Treatment
Hand, foot and mouth disease (HFMD) is a very common viral infection that predominantly affects children under the age of 5, ...
Relief for eczema flare-ups: How to manage symptoms if your skin condition worsens
When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.
I Have Eczema, and These Are the Products That Don't Bother My Skin
These ten essentials keep my skin hydrated, soothed, and protected from inflammation, itchiness, and occasional scaliness.
Mothership.sg13d
Teen, 18, opens up about her struggle with eczema in S’pore, where stress, sweat & heat cause flare-ups
During exam seasons or other stressful periods, her eczema inevitably flares up. When it gets too hot and humid and she ...
Singapore seeing more cases of moderate to severe eczema
KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...
Managed Healthcare Executive2d
FDA Approves Nemluvio for Atopic Dermatitis
This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...